A multicenter prospective observational study on the structured parenteral opioid intervention for dyspnea in terminally-ill cancer patients

Not Applicable

• Conditions: Advanced cancer

• Registration Number: JPRN-UMIN000039147
• Lead Sponsor: Seirei Mikatahara General Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-01-20
• Study Completion: 2021-06-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who will receive treatent for dyspnea that clearly has no direct pathophysiological association with cancer 2) Patients who are planning to undergo interventions that would change symptom intensity during a short period within 3 days. 3) Patient or family decline to participation

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The percentage of patients who receive a structured parenteral opioid intervention at 24 (18-30) hours after the initiation of the intervention for dyspnea

Secondary Outcome Measures

Name	Time	Method
The percentage of the utilization of a structured parenteral opioid intervention, achievement of treatment goals, contents of concurrent treatment such as increase and/or switching of opioids and benzodiazepines, dyspnea intensity, communication capacity and consciousness level, adverse events and dose-limiting toxicities, etc.